Affiliation:
1. Pacific State Medical University
2. Pacific State Medical University; FSBIH «Far-Eastern District Medical Center of Federal Medical Biological Agency»
Abstract
Palliative endobiliary interventions for malignant obstruction of the biliary tract at the planning stage require a multidisciplinary approach with mandatory consideration of all the anatomical features of the block and clinical manifestations of the pathology. Transhepatic stenting requires differentiated use of both the design features of biliary stents and the technology of their implantation and positioning. This article discusses the promise of intraductal ablation, brachytherapy, photodynamic therapy, and external beam radiation, which can prolong biliary stent patency and minimize the need for repeated intervention.
Publisher
Pacific State Medical University
Reference17 articles.
1. Shim DJ, Gwon DI, Han K, Kim Y, Ko GY, Shin JH, Ko HK, Kim JH, Kim JW, Yoon HK, Sung KB. Percutaneous Metallic Stent Placement for Palliative Management of Malignant Biliary Hilar Obstruction. Korean J Radiol. 2018; 19(4):597–605. doi: 10.3348/kjr.2018.19.4.597.
2. Ahn SJ, Bae JI, Han TS, Won JH, Kim JD, Kwack KS, Lee JH, Kim YC. Percutaneous biliary drainage using open cell stents for malignant biliary hilar obstruction. Korean J Radiol. 2012; 13(6):795–802. doi: 10.3348/kjr.2012.13.6.795.
3. Corvino F, Centore L, Soreca E, Corvino A, Farbo V, Bencivenga A. Percutaneous "Y" biliary stent placement in palliative treatment of type 4 malignant hilar stricture. J Gastrointest Oncol. 2016; 7(2): 255–61. doi: 10.3978/j.issn.2078-6891.2015.069.
4. Kapoor BS, Mauri G, Lorenz JM. Management of Biliary Strictures: State-of-the-Art Review. Radiology. 2018; 289(3): 590–603. doi: 10.1148/radiol.2018172424.
5. Mansour JC, Aloia TA, Crane CH, Heimbach JK, Nagino M, Vauthey JN. Hilar cholangiocarcinoma: expert consensus statement. HPB (Oxford). 2015;17(8):691-9. doi: 10.1111/hpb.12450.